Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Nan-Mo Moon"'
Autor:
Dong Wook Choi, Nan Mo Moon, Woo Chul Noh, Nam Sun Paik, Sung Ku Kang, Kwangmo Yang, Min Suk Kim, Sang Bum Kim, Chul Koo Cho, Jong Inn Lee
Publikováno v:
World Journal of Surgery. 29:1001-1006
The aims of study were to compare the rates of ipsilateral breast tumor recurrence (IBTR), for patients treated with either quadrantectomy or lumpectomy at a single institution, and to identify predictors of IBTR after breast-conserving therapy (BCT)
Autor:
Ho Yoon Bang, Jin Haeng Jung, Nan Mo Moon, Woo Chul Noh, Jong Inn Lee, Dong Wook Choi, Sang Han Yu, Nam Sun Paik, Dae Yong Hwang
Publikováno v:
Cancer Research and Treatment. 33:463-468
Purpose Primary sarcoma and SMC (sarcomatous metaplastic carcinoma) of the breast are very rare tumors, accounting for less than 1% of all breast malignancies. There are many controversies concerning the biological characteristics, prognosis and opti
Autor:
Sung Won Kim, Min Hyuk Lee, Eun Kyu Kim, Nan Mo Moon, Sung Yong Kim, Jae Jeong Yang, Young Jin Suh, Eunyoung Kang, Jihyoun Lee, Sei Hyun Ahn, Sue K. Park, Han-Wook Yoo, Soo Jung Lee, Hyung Jung Cho
Publikováno v:
Journal of Breast Cancer
PURPOSE Systematic educational programs and genetic counseling certification courses for hereditary breast/ovarian cancer (HBOC) have not yet been introduced in Korea. We provided and evaluated the effects of genetic counseling education on Korean he
Autor:
Kwan-il Kim, Nan Mo Moon, Woo Chul Noh, Min Suk Kim, Jong Inn Lee, Eunyoung Ko, Eun Kyu Kim, Jae Soo Koh, Hyun-Ah Kim
Publikováno v:
Breast cancer research and treatment. 126(1)
Cross-talk between the estrogen receptor and the mammalian target of rapamycin (mTOR) pathway is one of the mechanisms of endocrine therapy resistance, and the phosphorylated S6 kinase 1(p-S6K1) is known to be a marker of the mTOR pathway activation.
Publikováno v:
Breast cancer research and treatment. 110(3)
Rapamycin and its analogues are currently being tested in clinical trials as novel–targeted anticancer agents. Pre-clinical studies that used breast cancer cell lines have suggested that p-Akt or p-S6K1 expressing tumors, as well as PTEN negative t
Publikováno v:
Surgery. 137:109-110
Autor:
Hoe-Min Yang, Nan Mo Moon, Eun Kyu Kim, Woo Chul Noh, Kwan-il Kim, Nam-Sun Paik, Ju Young Lee, Hyun-Ah Kim, Jong Inn Lee, Min Suk Kim, Jae Soo Koh, Eunyoung Ko
Publikováno v:
Journal of Breast Cancer. 14:S10
Purpose: B-cell lymphoma (bcl)-2 is an anti-apoptotic gene, and it is a poor prognostic factor in various malignant tumors. However, the prognostic significance of bcl-2 expression in breast cancer remains controversial. We investigated the prognosti
Autor:
Jong-Inn Lee, Kwangmo Yang, Woo-Chul Noh, Hyun-Ah Kim, Eun-Jeong Jo, Yang Hee Kim, Min Suk Kim, Nan-Mo Moon, Nam-Sun Paik
Publikováno v:
Journal of Breast Cancer. 12:265
Purpose: False negative results obtained with the use of a sentinel lymph node biopsy (SLNB) can result in down staging of tumors, whereas the use of a more elaborated pathological examination of sentinel lymph nodes might lead to upstaging of tumors
Autor:
Woo-Chul Noh, Jea-Hwan Lee, Dong-Sun Shin, Yang Hee Kim, Nam-Sun Paik, Nan-Mo Moon, Hyun-Ah Kim
Publikováno v:
Journal of Breast Cancer. 11:133
younger than 40 yr of age, treated with chemotherapy regimens other than Cyclophosphamide, Methotrexate, 5-Flurouracil (CMF), without a history of tamoxifen therapy, and with a higher BMI. The multivariate analysis confirmed that the type of chemothe
Publikováno v:
Journal of the Korean Gastric Cancer Association. 8:9
Purpose: Gastric cancer is the most common malignant tumor in Korea. We reviewed the cases at our institution to identify the survival rates and clarify the prognostic factors of patients with gastric cancer. Materials and Methods: We conducted a ret